IPH-5201 | m-entrepreneurship.com

Product Name :
IPH-5201

Search keywords :
CD39

drugId :
null

Target Vo:
Ectonucleoside triphosphate diphosphohydrolase 1

Target Vo Short Name :
CD39

Moa_Name:
Ectonucleoside triphosphate diphosphohydrolase 1 inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Inserm

Active Company_Name :
Astrazeneca Plc

Active Indication_Name:
Carcinoma, Non-Small-Cell Lung

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Phase 2 Clinical

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
BDNF Antibody
Cyclin D2 Antibody (YA789)
GRP78 BiP Antibody (YA746): GRP78 BiP Antibody (YA746) is a non-conjugated and Mouse origined monoclonal antibody about 72 kDa, targeting to GRP78 BiP (4F11). It can be used for WB,ICC/IF,IP assays with tag free, in the background of Human, Mouse, Rat.

Author: Betaine hydrochloride

Related Posts